Aditya Gorla1, Brandon Jew2, Luke Zhang3, Jae Hoon Sul4. 1. Department of Bioengineering, University of California, Los, Los, U.S.A Angeles, Angeles, CA 90095. 2. Bioinformatics Interdepartmental Program, University of California, Los Angeles, CA 90095, Los, U.S.A. Angeles. 3. Undergraduate Neuroscience Interdepartmental Program, University of California, Los Angeles, CA 90095, Los, U.S.A. Angeles. 4. Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, CA 90095, Los, U.S.A Angeles.
Abstract
MOTIVATION: Since the first human genome was sequenced in 2001, there has been a rapid growth in the number of bioinformatic methods to process and analyze next generation sequencing (NGS) data for research and clinical studies that aim to identify genetic variants influencing diseases and traits. To achieve this goal, one first needs to call genetic variants from NGS data which requires multiple computationally intensive analysis steps. Unfortunately, there is a lack of an open source pipeline that can perform all these steps on NGS data in a manner which is fully automated, efficient, rapid, scalable, modular, user-friendly and fault tolerant. To address this, we introduce xGAP, an extensible Genome Analysis Pipeline, which implements modified GATK best practice to analyze DNA-seq data with aforementioned functionalities. RESULTS: xGAP implements massive parallelization of the modified GATK best practice pipeline by splitting a genome into many smaller regions with efficient load-balancing to achieve high scalability. It can process 30x coverage whole-genome sequencing (WGS) data in approximately 90 minutes. In terms of accuracy of discovered variants, xGAP achieves average F1 scores of 99.37% for SNVs and 99.20% for Indels across seven benchmark WGS datasets. We achieve highly consistent results across multiple on-premises (SGE & SLURM) high performance clusters. Compared to the Churchill pipeline, with similar parallelization, xGAP is 20% faster when analyzing 50X coverage WGS in AWS. Finally, xGAP is user-friendly and fault tolerant where it can automatically re-initiate failed processes to minimize required user intervention. AVAILABILITY: xGAP is available at https://github.com/Adigorla/xgap. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.
MOTIVATION: Since the first human genome was sequenced in 2001, there has been a rapid growth in the number of bioinformatic methods to process and analyze next generation sequencing (NGS) data for research and clinical studies that aim to identify genetic variants influencing diseases and traits. To achieve this goal, one first needs to call genetic variants from NGS data which requires multiple computationally intensive analysis steps. Unfortunately, there is a lack of an open source pipeline that can perform all these steps on NGS data in a manner which is fully automated, efficient, rapid, scalable, modular, user-friendly and fault tolerant. To address this, we introduce xGAP, an extensible Genome Analysis Pipeline, which implements modified GATK best practice to analyze DNA-seq data with aforementioned functionalities. RESULTS: xGAP implements massive parallelization of the modified GATK best practice pipeline by splitting a genome into many smaller regions with efficient load-balancing to achieve high scalability. It can process 30x coverage whole-genome sequencing (WGS) data in approximately 90 minutes. In terms of accuracy of discovered variants, xGAP achieves average F1 scores of 99.37% for SNVs and 99.20% for Indels across seven benchmark WGS datasets. We achieve highly consistent results across multiple on-premises (SGE & SLURM) high performance clusters. Compared to the Churchill pipeline, with similar parallelization, xGAP is 20% faster when analyzing 50X coverage WGS in AWS. Finally, xGAP is user-friendly and fault tolerant where it can automatically re-initiate failed processes to minimize required user intervention. AVAILABILITY: xGAP is available at https://github.com/Adigorla/xgap. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.
Authors: Aaron McKenna; Matthew Hanna; Eric Banks; Andrey Sivachenko; Kristian Cibulskis; Andrew Kernytsky; Kiran Garimella; David Altshuler; Stacey Gabriel; Mark Daly; Mark A DePristo Journal: Genome Res Date: 2010-07-19 Impact factor: 9.043
Authors: Peter Krusche; Len Trigg; Paul C Boutros; Christopher E Mason; Francisco M De La Vega; Benjamin L Moore; Mar Gonzalez-Porta; Michael A Eberle; Zivana Tezak; Samir Lababidi; Rebecca Truty; George Asimenos; Birgit Funke; Mark Fleharty; Brad A Chapman; Marc Salit; Justin M Zook Journal: Nat Biotechnol Date: 2019-03-11 Impact factor: 54.908
Authors: Mark A DePristo; Eric Banks; Ryan Poplin; Kiran V Garimella; Jared R Maguire; Christopher Hartl; Anthony A Philippakis; Guillermo del Angel; Manuel A Rivas; Matt Hanna; Aaron McKenna; Tim J Fennell; Andrew M Kernytsky; Andrey Y Sivachenko; Kristian Cibulskis; Stacey B Gabriel; David Altshuler; Mark J Daly Journal: Nat Genet Date: 2011-04-10 Impact factor: 38.330
Authors: Benjamin J Kelly; James R Fitch; Yangqiu Hu; Donald J Corsmeier; Huachun Zhong; Amy N Wetzel; Russell D Nordquist; David L Newsom; Peter White Journal: Genome Biol Date: 2015-01-20 Impact factor: 13.583
Authors: Yuk Yee Leung; Otto Valladares; Yi-Fan Chou; Han-Jen Lin; Amanda B Kuzma; Laura Cantwell; Liming Qu; Prabhakaran Gangadharan; William J Salerno; Gerard D Schellenberg; Li-San Wang Journal: Bioinformatics Date: 2019-06-01 Impact factor: 6.937
Authors: Jacob R Heldenbrand; Saurabh Baheti; Matthew A Bockol; Travis M Drucker; Steven N Hart; Matthew E Hudson; Ravishankar K Iyer; Michael T Kalmbach; Katherine I Kendig; Eric W Klee; Nathan R Mattson; Eric D Wieben; Mathieu Wiepert; Derek E Wildman; Liudmila S Mainzer Journal: BMC Bioinformatics Date: 2019-11-08 Impact factor: 3.169